Size | Price | Stock | Qty |
---|---|---|---|
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
2g |
|
||
5g |
|
||
Other Sizes |
|
Purity: ≥98%
Procarbazine HCl (formerly NSC77213; Ro4-6467; CB-400-497; PCB; PCZ; Matulane; Natulanar), the hydrochloride salt form of procarbazine, is an anticancer chemotherapeutic medication approved for the treatment of Hodgkin's lymphoma and certain brain cancers.
Molecular Formula |
C12H19N3O.HCL
|
|
---|---|---|
Molecular Weight |
257.76
|
|
Exact Mass |
221.15
|
|
Elemental Analysis |
C, 55.92; H, 7.82; Cl, 13.75; N, 16.30; O, 6.21
|
|
CAS # |
366-70-1
|
|
Related CAS # |
671-16-9
|
|
Appearance |
Solid powder
|
|
SMILES |
CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl
|
|
InChi Key |
DERJYEZSLHIUKF-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C12H19N3O.ClH/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3;/h4-7,9,13-14H,8H2,1-3H3,(H,15,16);1H
|
|
Chemical Name |
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
---|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.8796 mL | 19.3979 mL | 38.7958 mL | |
5 mM | 0.7759 mL | 3.8796 mL | 7.7592 mL | |
10 mM | 0.3880 mL | 1.9398 mL | 3.8796 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT00887146 | Recruiting | Drug: procarbazine Drug: CCNU |
Brain and Central Nervous System Tumors |
Alliance for Clinical Trials in Oncology |
September 2009 | Phase 3 |
NCT03495960 | Recruiting | Drug: Rituximab Drug: Procarbazine |
Primary Central Nervous System Lymphoma |
International Extranodal Lymphoma Study Group (IELSG) |
June 15, 2019 | Phase 2 |
NCT05425654 | Recruiting | Drug: Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide |
Primary CNS Lymphoma | National Research Center for Hematology, Russia |
May 17, 2021 | Phase 2 |